ClinicalTrials.Veeva

Menu

Evaluate the Predictive Impact of the MEESSI Score

U

University of Monastir

Status

Enrolling

Conditions

Emergencies
Heart Diseases

Treatments

Diagnostic Test: MEESSI score

Study type

Observational

Funder types

Other

Identifiers

NCT05340972
MEESSI 2022

Details and patient eligibility

About

Our primary purpose is to assess MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department.

European Society of Cardiology recommend risk stratification for patients with AHF.

Full description

Improved risk stratification of acute heart failure (AHF) in the emergency department (ED) may help physicians' decisions regarding patient admission or early discharge disposition. The MEESSI-AHF (Multiple Estimation of risk based on the Emergency department Spanish Score In patients with AHF) score was developed to predict 30-day mortality in patients presenting with AHF EDs in Spain. Whether it performs well in other countries is unknown.

The MEESSI-AHF risk model includes 13 variables readily available on arrival to Emergency Department. The 40% of patients classified as LOW RISK (30-day mortality: <2%) should be considered as potential candidates to be early discharged from Emergency Department without admission after adequate response to initial treatment. The 10% of patients classified as VERY HIGH RISK (30-day mortality: >2%) may clearly benefit from hospital admission.

Objective: To externally validate the MEESSI-AHF score in another country.

Enrollment

1,500 estimated patients

Sex

All

Ages

18 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major patient
  • Patient admitted to emergencies with final diagnosis of AHF according to the opinion of two emergency experts after consulting the data from the clinical examination, cardiac echocardiography, and BNP level.
  • Subject who accept to participate in the research

Exclusion criteria

  • Patient who refuse to participate in the study
  • Patient with coronary syndrome with ST segment elevation
  • Other causes of dyspnea
  • Impossibility of giving the patient informed information
  • Pregnant woman

Trial contacts and locations

1

Loading...

Central trial contact

Khaoula Bel Haj Ali, MD; Semir Nouira, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems